Physician profile
Jamie Lee Teal
NPI 1861937302
$7,148.98
in general payments reported to CMS, 2019-2025
34 companies · $2,580 in 2025
The $2,580 reported for 2025 was more than what 93% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $766 · 2023: $1,391 · 2024: $1,993 · 2025: $2,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,561 · Education: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,561.16 |
| Education | $403.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,001.54 | 2021-2025 | Airsupra, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $881.84 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $831.76 | 2021-2025 | Dupixent |
| Harmony Biosciences LLC | $491.95 | 2023-2025 | Wakix |
| United Therapeutics Corporation | $298.06 | 2022-2025 | Tyvaso, Tyvaso, Orenitram |
| Amgen INC. | $286.49 | 2022-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $215.00 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.59 | 2021-2025 | Ofev, Jascayd |
| Pulmonx Corporation | $197.69 | 2024-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Genzyme Corporation | $181.04 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $138.40 | 2022-2024 | Acthar |
| Genentech USA, INC. | $129.69 | 2022-2024 | Xolair |
| Baxter Healthcare | $105.33 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Merck Sharp & Dohme LLC | $104.42 | 2025 | Winrevair, Zerbaxa |
| Takeda Pharmaceuticals U.S.A., INC. | $102.86 | 2025 | Glassia |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $92.30 | 2022-2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $91.27 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $89.53 | 2024-2025 | Sunosi |
| Novartis Pharmaceuticals Corporation | $80.25 | 2021-2025 | |
| Insmed, INC. | $79.64 | 2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $78.90 | 2021-2024 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $66.80 | 2025 | Lumryz |
| Electromed, INC. | $57.88 | 2023-2025 | Smartvest |
| Csl Behring | $43.13 | 2023 | Hizentra |
| Abbvie INC. | $40.76 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $40.30 | 2024-2025 | Opsumit |
| Inspire Medical Systems, INC. | $40.05 | 2024 | Inspire |
| Verona Pharma, INC. | $37.29 | 2025 | Ohtuvayre |
| Philips North America LLC | $31.13 | 2022-2025 | Vest Therapy Und |
| Pfizer INC. | $30.90 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $22.28 | 2022 | |
| Inogen, INC. | $17.00 | 2025 | |
| Fisher & Paykel Healthcare INC | $15.80 | 2025 | Fisher & Paykel Healthcare |
| Phadia US INC. | $15.11 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Teal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.